Literature DB >> 9613736

Cinnarizine-induced parkinsonism: ten years later.

J F Martí-Massó1, J J Poza.   

Abstract

A retrospective study was carried out to investigate the evolution of patients diagnosed with cinnarizine-induced parkinsonism (CIP) over the past 15 years. A total of 74 cases of CIP were found among 172 patients with drug-induced parkinsonism (DIP). Both CIP and other DIP were significantly more frequent in women. No clinical differences between CIP and other DIP were found. Most of the patients (66 of 74) completely recovered after cinnarizine withdrawal in 1-16 months. Eleven patients later developed Parkinson's disease; four of them had previously recovered. Five patients had tardive dyskinesia. CIP accounts for a high proportion of DIP referred to neurologists in populations in which cinnarizine is widely prescribed. The symptoms typically resolve after drug withdrawal, although complete recovery may take more than 1 year.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613736     DOI: 10.1002/mds.870130313

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  10 in total

1.  Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.

Authors:  Hae-Won Shin; Jae Seung Kim; Minyoung Oh; Sooyeoun You; Young Jin Kim; Juyeon Kim; Mi-Jung Kim; Sun Ju Chung
Journal:  Neurol Sci       Date:  2014-09-18       Impact factor: 3.307

2.  Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.

Authors:  Renato P Munhoz; Delcio Bertucci Filho; Hélio A G Teive
Journal:  Neurol Sci       Date:  2016-11-16       Impact factor: 3.307

Review 3.  Drug-induced parkinsonism in the elderly: incidence, management and prevention.

Authors:  José Luis López-Sendón; María Angeles Mena; Justo García de Yébenes
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

4.  Microstructural white matter alterations in patients with drug induced parkinsonism.

Authors:  Yoonju Lee; Yong Ho Choi; Jae Jung Lee; Hye Sun Lee; Young H Sohn; Jong-Min Lee; Phil Hyu Lee
Journal:  Hum Brain Mapp       Date:  2017-09-12       Impact factor: 5.038

5.  Drug-induced parkinsonism.

Authors:  Hae-Won Shin; Sun Ju Chung
Journal:  J Clin Neurol       Date:  2012-03-31       Impact factor: 3.077

6.  Parkinsonism and Tremor Complicating Long-term Cinitapride Use.

Authors:  Aaron de Souza; Rainha J de Souza
Journal:  Ann Indian Acad Neurol       Date:  2017 Oct-Dec       Impact factor: 1.383

7.  Asymmetric Drug-Induced Parkinsonism and Psychopathology: A Prospective Naturalistic Study in Long-Stay Psychiatric Patients.

Authors:  Lydia E Pieters; P Roberto Bakker; Peter N van Harten
Journal:  Front Psychiatry       Date:  2018-02-05       Impact factor: 4.157

8.  Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.

Authors:  Kai-Ming Jhang; Jing-Yang Huang; Oswald Ndi Nfor; Yu-Chun Tung; Wen-Yuan Ku; Chun-Te Lee; Yung-Po Liaw
Journal:  Eur J Clin Pharmacol       Date:  2017-04-06       Impact factor: 2.953

9.  Flunarizine related movement disorders: a nationwide population-based study.

Authors:  Kai-Ming Jhang; Jing-Yang Huang; Oswald Ndi Nfor; Yu-Chun Tung; Wen-Yuan Ku; Cheng-Feng Jan; Yung-Po Liaw
Journal:  Sci Rep       Date:  2019-02-08       Impact factor: 4.379

10.  Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study.

Authors:  Foad Taghdiri; Mansoureh Togha; Soodeh Razeghi Jahromi; Farshid Refaeian
Journal:  Springerplus       Date:  2014-05-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.